rs782748026

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2

The NM_001111125.3(IQSEC2):​c.1926G>A​(p.Pro642Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,207,288 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.000012 ( 0 hom. 3 hem. )

Consequence

IQSEC2
NM_001111125.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -1.69

Publications

0 publications found
Variant links:
Genes affected
IQSEC2 (HGNC:29059): (IQ motif and Sec7 domain ArfGEF 2) This gene encodes a guanine nucleotide exchange factor for the ARF family of small GTP-binding proteins. The encoded protein is a component of the postsynaptic density at excitatory synapses, and may play a critical role in cytoskeletal and synaptic organization through the activation of selected ARF substrates including ARF1 and ARF6. Mutations in this gene have been implicated in nonsyndromic X-linked cognitive disability. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Aug 2011]
IQSEC2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • intellectual disability, X-linked 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • severe intellectual disability-progressive postnatal microcephaly- midline stereotypic hand movements syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant X-53250650-C-T is Benign according to our data. Variant chrX-53250650-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 197718.
BP7
Synonymous conserved (PhyloP=-1.69 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 5 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IQSEC2NM_001111125.3 linkc.1926G>A p.Pro642Pro synonymous_variant Exon 5 of 15 ENST00000642864.1 NP_001104595.1 Q5JU85-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IQSEC2ENST00000642864.1 linkc.1926G>A p.Pro642Pro synonymous_variant Exon 5 of 15 NM_001111125.3 ENSP00000495726.1 Q5JU85-2

Frequencies

GnomAD3 genomes
AF:
0.000134
AC:
15
AN:
111939
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000487
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000454
AC:
8
AN:
176058
AF XY:
0.0000315
show subpopulations
Gnomad AFR exome
AF:
0.000674
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000119
AC:
13
AN:
1095349
Hom.:
0
Cov.:
33
AF XY:
0.00000830
AC XY:
3
AN XY:
361305
show subpopulations
African (AFR)
AF:
0.000341
AC:
9
AN:
26378
American (AMR)
AF:
0.00
AC:
0
AN:
35148
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19285
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30159
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54014
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39501
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4124
European-Non Finnish (NFE)
AF:
0.00000357
AC:
3
AN:
840810
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000134
AC:
15
AN:
111939
Hom.:
0
Cov.:
23
AF XY:
0.000146
AC XY:
5
AN XY:
34133
show subpopulations
African (AFR)
AF:
0.000487
AC:
15
AN:
30780
American (AMR)
AF:
0.00
AC:
0
AN:
10673
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2638
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3533
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2725
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6112
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53052
Other (OTH)
AF:
0.00
AC:
0
AN:
1508
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000166

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Oct 01, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 11, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability, X-linked 1 Benign:1
Dec 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 09, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.94
DANN
Benign
0.48
PhyloP100
-1.7
PromoterAI
-0.015
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782748026; hg19: chrX-53279832; API